Association between matrix metalloproteinase‐9 and worsening heart failure events in patients with chronic heart failure

AIMS: Matrix metalloproteinase (MMP) is up‐regulated during heart failure (HF) and influences ventricular remodeling. We hypothesized that disparity between MMP‐9 and tissue inhibitors of MMP‐1 (TIMP‐1) results in clinical manifestations and is related to prognostic risk in patients with chronic HF....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:ESC Heart Fail
Autors principals: Morishita, Tetsuji, Uzui, Hiroyasu, Mitsuke, Yasuhiko, Amaya, Naoki, Kaseno, Kenichi, Ishida, Kentaro, Fukuoka, Yoshitomo, Ikeda, Hiroyuki, Tama, Naoki, Yamazaki, Taketoshi, Lee, Jong‐Dae, Tada, Hiroshi
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2017
Matèries:
Original Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5542740/
https://ncbi.nlm.nih.gov/pubmed/28772055
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12137
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars